IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CANCARINI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.375
EU - Europa 7.568
AS - Asia 5.970
SA - Sud America 1.226
AF - Africa 140
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 27.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.222
CN - Cina 2.189
SG - Singapore 1.978
IT - Italia 1.835
PL - Polonia 1.551
UA - Ucraina 1.464
BR - Brasile 1.019
DE - Germania 769
HK - Hong Kong 673
FI - Finlandia 414
FR - Francia 414
VN - Vietnam 362
GB - Regno Unito 332
RU - Federazione Russa 260
IE - Irlanda 222
TR - Turchia 222
IN - India 181
BD - Bangladesh 76
AR - Argentina 67
CA - Canada 64
NL - Olanda 60
SE - Svezia 59
MX - Messico 55
BE - Belgio 51
ID - Indonesia 46
IQ - Iraq 43
EC - Ecuador 41
ZA - Sudafrica 35
NG - Nigeria 34
VE - Venezuela 26
PK - Pakistan 25
AT - Austria 24
JP - Giappone 23
CZ - Repubblica Ceca 22
ES - Italia 22
CO - Colombia 20
IR - Iran 20
PY - Paraguay 19
UZ - Uzbekistan 19
MA - Marocco 17
SA - Arabia Saudita 16
AU - Australia 15
EG - Egitto 15
CL - Cile 13
EU - Europa 13
JO - Giordania 13
LT - Lituania 13
PE - Perù 10
RO - Romania 10
TN - Tunisia 10
KZ - Kazakistan 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
HN - Honduras 8
OM - Oman 8
KE - Kenya 7
DZ - Algeria 6
HR - Croazia 6
NP - Nepal 6
UY - Uruguay 6
BG - Bulgaria 5
CH - Svizzera 5
ET - Etiopia 5
IL - Israele 5
JM - Giamaica 5
KR - Corea 5
LB - Libano 5
LV - Lettonia 5
PH - Filippine 5
BO - Bolivia 4
PA - Panama 4
PS - Palestinian Territory 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
KW - Kuwait 3
MY - Malesia 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
GR - Grecia 2
GT - Guatemala 2
MD - Moldavia 2
ML - Mali 2
MU - Mauritius 2
PR - Porto Rico 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
Totale 27.292
Salva come PNG Salva come JPEG
Città #
Warsaw 1.548
Fairfield 1.359
Woodbridge 1.152
Jacksonville 1.048
Singapore 1.043
Ashburn 991
Houston 786
Hong Kong 670
Ann Arbor 618
Chandler 593
Cambridge 591
Seattle 505
Wilmington 463
The Dalles 437
Princeton 418
Beijing 414
Nanjing 370
San Jose 304
New York 262
Dublin 219
Milan 213
Helsinki 212
Dallas 210
Istanbul 186
Lauterbourg 184
Los Angeles 155
Nanchang 137
Ho Chi Minh City 131
Munich 125
Dearborn 113
Rome 110
Des Moines 107
Brescia 101
Buffalo 101
Hebei 82
Moscow 80
Shenyang 79
São Paulo 78
Jiaxing 77
Changsha 75
San Diego 73
Tianjin 72
Hanoi 65
Jinan 53
Shanghai 53
Verona 49
Redondo Beach 48
Brussels 47
Council Bluffs 46
Dong Ket 44
Kunming 40
London 40
Chicago 38
San Francisco 36
Boardman 35
Abuja 34
Chennai 34
Naples 34
Orem 33
Hangzhou 32
Florence 31
Rio de Janeiro 30
Santa Clara 30
Turin 30
Toronto 29
Lanzhou 28
Belo Horizonte 26
Atlanta 24
Ningbo 24
Stockholm 24
Frankfurt am Main 23
Lancaster 23
San Mateo 23
Turku 23
Mexico City 22
Nuremberg 22
Bologna 21
Brooklyn 21
Tokyo 21
Zhengzhou 21
Brno 20
Jakarta 20
Augusta 19
Bergamo 19
Curitiba 19
Falls Church 19
Guangzhou 19
Monmouth Junction 18
Phoenix 17
Amsterdam 16
Baghdad 16
Bari 16
Denver 16
Leawood 16
Mumbai 16
Taizhou 16
Tashkent 16
Ardabil 15
Brasília 15
Changchun 15
Totale 18.092
Salva come PNG Salva come JPEG
Nome #
Mancata ripopolazione dei B linfociti periferici dopo un singolo ciclo di Rituximab in pazienti con vasculite ANCA associata (AAV) all'esordio mai esposti in precedenza a farmaci immunosoppressivi 1.204
Vasculiti ANCA associate (AAV) con presenza di indicatore sierico di attivazione della via alterna del complemento: valutazione degli outcomes. 467
Incremental peritoneal dialysis: a 10 year single-centre experience 323
PRIMA E DOPO IL TRAPIANTO DI RENE: EMODIALISI VS. DIALISI PERITONEALE. 294
SOVRAPPESO POST-DIALITICO E INFIAMMAZIONE CRONICA: UNA ASSOCIAZIONE PERICOLOSA. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI. 268
Low-protein diets for chronic kidney disease patients: The Italian experience 262
Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity. 252
CORREZIONE DELL’IPOVITAMINOSI D [25(OH)D3] NEL PAZIENTE DIALIZZATO. EFFETTI SUL METABOLISMO CALCIO-FOSFORICO 252
SCLEROSI PERITONEALE INCAPSULANTE IN DIALISI PERITONEALE: UNA “BELVA” IN GABBIA? 251
EFFETTO DELLA TERAPIA CON INIBITORI DEL SISTEMA RENINA-ANGIOTENSINA SUI LIVELLI SIERICI DI POTASSIO NEI PAZIENTI EMODIALIZZATI. UNO STUDIO OSSERVAZIONALE 250
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 247
END-DIALYSIS OVERWEIGHT AND CHRONIC INFLAMMATION. A DANGEROUS CONNECTION 244
Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients. 244
Varianti della malattia da anticorpi anti-GBM (mAbGBM): malattia renale da anticorpi anti-GBM in assenza di anticorpi circolanti 231
L’ENTITÀ’ DEL SOVRAPPESO POST-DIALITICO E’ ASSOCIATO CON LA MORTALITA’ TOTALE E CARDIOVASCOLARE NEI PAZIENTI EMODIALIZZATI. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI 230
PERITONITE DA MYCOBACTERIUM ABSCESSUS IN CAPD: CASE REPORT. 224
RUOLO DELLA COMPONENTE CONVETTIVA SULLE VARIAZIONI SIERICHE DI BETA 2 MICROGLOBULINA (?B2M), PROTEINA C REATTIVA (?HSCRP), E FABBISOGNO DI EPO (?EPO) IN PAZIENTI EMODIALIZZATI TRATTATI CON HDF ON-LINE POST DILUZIONALE. 223
IL RUOLO DEL GRADIENTE DIALITICO DEL SODIO SULL’AUMENTO DEI VALORI DI PRESSIONE ARTERIOSA DURANTE LA DIALISI. UNO STUDIO OSSERVAZIONALE 204
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 189
A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report. 185
Pregnancy outcomes after kidney graft in Italy: Are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 183
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 180
Vascular access in older patients: an Italian survey. 178
Assessment of Vascular Structural and Functional Alterations In Apolipoprotein A-i Amyloidosis (leu75pro) 177
Differing dialysis treatment strategies and outcome. 175
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: Results of the FARO-2 cohort 174
A more tubulocentric view of diabetic kidney disease 174
The MEST score provides earlier risk prediction in lgA nephropathy 173
Nutritional treatment of advanced CKD: twenty consensus statements 172
Magnitude of End-Dialysis Overweight is Associated with All-Cause and Cardiovascular Mortality: A 3-Year Prospective Study. 171
A six year comparison of patient and technique survivals in CAPD and HD 170
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients 170
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 170
A randomized controlled trial of a bicarbonate - and a bicarbonate/lactate - containing dialysis solution in CAPD 169
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 168
A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects. 167
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 165
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. 164
Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. 163
Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. 162
Total Convection Affects Serum β2 Microglobulin and C-Reactive Protein but Not Erythropoietin Requirement following Post-Dilutional Hemodiafiltration 160
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? 155
Monoclonal Lambda Free Liht Chains:biochemical behavoiur and pathogenetic classification 154
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 154
Access site-related infection in dialysis: the AStRID project: a multicenter prospective Italian study. 153
TRANSUDATIVE PLEURAL EFFUSION DUE TO PLEUROPERITONEAL COMMUNICATION IN PERITONEAL DIALYSIS PATIENTS WITH POLYCISTIC KIDNEY DISEASE 152
A competing risks model with a time dependent variable: the effects of hypertension onset in the comorbidities history in type 2 diabetes 150
PERITONITE IN DP: CONFRONTO TRA METODICHE 145
Assessment of calcemic status in dialyzed uraemic patients. 144
Which vascular access for chronic hemodialysis in uremic elderly patients? 143
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 140
Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. 140
How to manage elderly patients with chronic renal failure: conservative management versus dialysis 139
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study 139
Adeguatezza del trattamento dialitico: aspetti pratici. 138
Clinical policies on the management of chronic kidney disease patients in Italy. 138
Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study 138
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 137
Porphyria and pseudo-porphyria in hemodialyzed patients. 136
Experience with cyclosporine. 136
Carotid Artery Structural Alterations In Patients With Apolipoprotein A-i Amyloidosis (leu75pro) 136
Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy. 136
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. 136
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. 135
Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: a longitudinal study. 135
Myocardial ultrasound tissue characterization in patients with chronic renal failure 135
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 135
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 135
MALNUTRITION INFLAMMATION SCORE AND RISK OF HOSPITALISATION AND MORTALITY IN PERITONEAL DIALYSIS PATIENTS. 135
Early (fifth day) vs. late (sixth month) steroid withdrawal in renal transplant recipients treated with Neoral((R)) plus Rapamune((R)): four-yr results of a randomized monocenter study. 134
Dialysis initiation: what's the rush? 134
Diethylene Glycol Poisoning From Transcutaneous Absorption 131
PD or not PD? That is the question. 131
Interrelationships between blood pressure, blood gases and plasma acetate concentrations during conventional hemodialysis. 130
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. 130
Encapsulating peritoneal sclerosis in an Italian center: thirty year experience 130
Transplantation outcome in patients PD and HD 129
Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. 129
Role of dialysis sodium gradient on intradialytic hypertension: an observational study. 129
Strategy for preventing peritoneal dialysis failure. 128
Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. 127
Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. 127
Porphyria cutanea tarda in a haemodialysed patient. 126
Management of hypertension in chronic renal failure. 126
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort 126
'Y' connector system for prevention of peritonitis in CAPD: a controlled study. 125
PERITONITE IN DP: DIABETICI vs. NON-DIABETICI 125
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 124
Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. 123
Retroperitoneal fibrosis at the onset of ANCA associated vasculitis: The risk of a delay in the diagnosis of vasculitis 123
Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications. 123
Renal transplantation and peritoneal dialysis 122
Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. 121
Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients. 121
Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study. 121
Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation. 121
Ciclosporina (Cs) nei trapianti di rene: è utile il monitoraggio dei through-levels (BTL)? 121
Re-treatment with rituximab in ANCA-associated vasculitis only in the presence of clinical relapse: A single centre experience 121
Renal anemia: comparing current Eastern and Western European management practice (ORAMA). 120
Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy. 120
Totale 17.476
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.559
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021779 0 0 0 0 0 0 0 0 0 262 358 159
2021/20221.692 114 298 45 106 42 88 98 146 80 210 139 326
2022/20231.820 239 22 28 185 167 476 24 202 268 24 86 99
2023/20241.448 92 35 68 109 61 226 69 85 358 34 44 267
2024/20253.634 50 78 44 363 486 291 368 150 431 264 670 439
2025/20265.985 563 864 678 952 528 455 896 238 407 404 0 0
Totale 27.593